THE KITASATO INST has a total of 42 patent applications. It increased the IP activity by 300.0%. Its first patent ever was published in 2000. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are HAWAII BIOTECH INC, MCKERRACHER LISA and NOVARTIS INT PHARM LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 8 | |
#3 | EPO (European Patent Office) | 6 | |
#4 | United States | 5 | |
#5 | Canada | 3 | |
#6 | China | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Hungary | 1 | |
#9 | Israel | 1 | |
#10 | Norway | 1 | |
#11 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Fermentation | |
#4 | Heterocyclic compounds | |
#5 | Microorganisms | |
#6 | Peptides | |
#7 | Microorganisms | |
#8 | Sugars | |
#9 | Acyclic or carbocyclic compounds | |
#10 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Omura Satoshi | 17 |
#2 | Tomoda Hiroshi | 11 |
#3 | Takahashi Yoko | 8 |
#4 | Nagase Hiroshi | 5 |
#5 | Fujii Hideaki | 5 |
#6 | Nakashima Takuji | 5 |
#7 | Watanabe Yoshikazu | 5 |
#8 | Nakata Eriko | 5 |
#9 | Takahashi Toshihiro | 5 |
#10 | Hashimoto Junko | 4 |
Publication | Filing date | Title |
---|---|---|
TW202015712A | Anti-influenza virus agent for suppressing aggravation of influenza | |
WO2019225639A1 | Method for diagnosing infection with helicobacter suis | |
WO2019189331A1 | Novel k95-5901-1 substance and method for producing same | |
CN110090235A | Extraction classification object and its preparation method and purposes containing the macromolecule condensed type tannin obtained by Herba Ephedrae extract or EFE | |
WO2019059132A1 | NOVEL NF-κB INHIBITOR | |
CN111278985A | Novel compound having therapeutic activity against mycobacterium avium complex infectious diseases and method for producing same | |
WO2018169055A1 | Novel pochoniolide compound and use thereof | |
WO2018056470A1 | Epithelial-mesenchymal transition induced cell inhibitor | |
US2017306371A1 | Method for producing trehangelin | |
EP2774926A1 | Morphinan derivative | |
CA2710611A1 | Method of producing japanese encephalitis vaccine stably storable over long time and use of the vaccine | |
CA2636914A1 | Oral composition containing interferon-.alpha. | |
AU2004317338A1 | Substances K01-0509 and process for producing the same | |
AU2002301970B2 | WK-5344A substance and WK-5344B substance and production thereof |